Search Results 21-30 of 20133 for alzheimers
An experimental drug for Alzheimer's disease shows promise to slow the progression of the diseas. A Mayo Clinic Neurologist gives perspective.
The most common gene linked to late-onset Alzheimer's disease is a risk gene called apolipoprotein E, also known as APOE. Genes can have many variations, also ...
Alzheimer's disease is a progressive neurologic disorder that causes memory loss and other cognitive decline due to brain cell degeneration.
Alzheimer's disease is the most common cause of dementia, which is a term used to describe a group of symptoms that affect memory, thinking and social abilities ...
In Alzheimer's disease, the brain cells degenerate and die, causing a steady decline in memory and mental function. At first, someone with Alzheimer's disease ...
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
The Mayo Clinic Alzheimer's Disease Research Center studies brain aging, Alzheimer's and related dementias. It provides support and resources to patients, ...
Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to ...
A potential new Alzheimer's disease drug shows promise. Hear what a Mayo Clinic researcher and expert has to say about the treatment.
Mayo Clinic experts from many disciplines, including neurology, neuroscience, psychology and psychiatry, collaborate to provide you with the best Alzheimer's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.